Literature DB >> 17892529

Insulin-like growth factor-binding protein-5 enters vesicular structures but not the nucleus.

Andreas Jurgeit1, Chiara Berlato, Peter Obrist, Christian Ploner, Petra Massoner, Judith Schmölzer, Michael C Haffner, Helmut Klocker, Lukas A Huber, Stephan Geley, Wolfgang Doppler.   

Abstract

In addition to its extracellular function as a secreted protein, IGF-binding protein (IGFBP)-5 has been postulated to act as a signaling molecule in the nucleus. This study aims to assess the significance of this postulated nuclear localization. By confocal immunofluorescence microscopy, we detected IGFBP-5 in the vesicular compartment of mammary epithelial cells in culture, while no nuclear staining was observed. Immunohistochemistry performed on paraffin sections of the involuting mammary gland revealed IGFBP-5 positive staining of epithelial cells only outside the nucleus. To evaluate the contribution of reuptake of extracellular IGFBP-5, T47D cells were incubated with Alexa Fluor 647-labeled IGFBP-5. The protein was taken up into intracellular vesicles and again was neither detectable in the cytoplasm outside of vesicular structures nor in the nucleus. Quantification of the time and concentration dependence of uptake by immunoblotting revealed that the process was saturable at IGFBP-5 concentrations between 1 and 2 mum and partially reversible with 30% remaining in the cell after a 1-h chase. The observation of nuclear uptake of IGFBP-5 was restricted to artificial conditions such as expression of non-secreted forms of IGFBP-5 or selective permeabilization of the plasma membrane by digitonin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17892529     DOI: 10.1111/j.1600-0854.2007.00655.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  9 in total

Review 1.  Role of insulin-like growth factor binding proteins in mammary gland development.

Authors:  D J Flint; E Tonner; J Beattie; G J Allan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-08       Impact factor: 2.673

2.  Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5.

Authors:  Yukie Yamaguchi; Hidekata Yasuoka; Donna B Stolz; Carol A Feghali-Bostwick
Journal:  J Cell Mol Med       Date:  2011-04       Impact factor: 5.310

3.  Precision-cut slice cultures of tumors from MMTV-neu mice for the study of the ex vivo response to cytokines and cytotoxic drugs.

Authors:  Nirmala Parajuli; Wolfgang Doppler
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-06-16       Impact factor: 2.416

Review 4.  IGF binding proteins in cancer: mechanistic and clinical insights.

Authors:  Robert C Baxter
Journal:  Nat Rev Cancer       Date:  2014-04-10       Impact factor: 60.716

Review 5.  IGF binding proteins (IGFBPs) and regulation of breast cancer biology.

Authors:  Claire M Perks; Jeff M P Holly
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-25       Impact factor: 2.673

6.  IGFBP-4 anti-angiogenic and anti-tumorigenic effects are associated with anti-cathepsin B activity.

Authors:  María J Moreno; Marguerite Ball; Marina Rukhlova; Jacqueline Slinn; Denis L'abbe; Umar Iqbal; Robert Monette; Martin Hagedorn; Maureen D O'Connor-McCourt; Yves Durocher; Danica B Stanimirovic
Journal:  Neoplasia       Date:  2013-05       Impact factor: 5.715

7.  Analysis of the quantitative balance between insulin-like growth factor (IGF)-1 ligand, receptor, and binding protein levels to predict cell sensitivity and therapeutic efficacy.

Authors:  Dan Tian; Pamela K Kreeger
Journal:  BMC Syst Biol       Date:  2014-08-13

8.  The subcellular localization of IGFBP5 affects its cell growth and migration functions in breast cancer.

Authors:  Mustafa Akkiprik; Limei Hu; Aysegul Sahin; Xishan Hao; Wei Zhang
Journal:  BMC Cancer       Date:  2009-04-03       Impact factor: 4.430

Review 9.  Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer.

Authors:  Mustafa Akkiprik; Yumei Feng; Huamin Wang; Kexin Chen; Limei Hu; Aysegul Sahin; Savitri Krishnamurthy; Ayse Ozer; Xishan Hao; Wei Zhang
Journal:  Breast Cancer Res       Date:  2008-08-11       Impact factor: 6.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.